FAQ/Help |
Calendar |
Search |
Today's Posts |
06-10-2014, 03:41 PM | #1 | ||
|
|||
Member
|
Adamas Pharmaceuticals Inc. announced that it has initiated a pivotal Phase 3 clinical study of ADS-5102 (amantadine HCl), a high-dose, controlled-release version of amantadine for the treatment of patients with Parkinson's disease who have developed levodopa-induced dyskinesia (LID).
http://www.dddmag.com/news/2014/06/a...4&location=top |
||
Reply With Quote |
06-15-2014, 05:55 PM | #2 | |||
|
||||
Senior Member
|
Amantadine helped control my dyskinesias somewhat, and mine can be so bad (and painful) that I would welcome anything! However, after my second week on Amantadine, my legs and feet swelled painfully and I had to stop the Amantadine.
Does anyone know if the "new and improved" Amantadine has similar side effects? Or does anyone know of something else that might be causing the swelling of my lower extremities? I take Sinemet, Comtan, Requip as my regular Parkinson's regime. Peggy |
|||
Reply With Quote |
06-15-2014, 09:54 PM | #3 | ||
|
|||
Member
|
Quote:
Gary |
||
Reply With Quote |
06-16-2014, 06:54 AM | #4 | ||
|
|||
Member
|
Three volunteers 0f the total group (N = 83) suffered from peripheral edema as an adverse side effect. Unfortunately, I don't know how that compares percentagewise with the original drug formulation. However, although only a small percentage (3.6%), it appears that some people will have lower limb swelling as a side effect.
|
||
Reply With Quote |
"Thanks for this!" says: | lab rat (06-17-2014), soccertese (06-16-2014) |
06-16-2014, 10:20 AM | #5 | |||
|
||||
Senior Member
|
Thank you, Gary. I guess I will just have to give the drug a trial run and hope for better results.
Thank you, also, anagirl for the link. Peg |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Diseas | Parkinson's Disease | |||
Depomed Initiates Phase I Trial for DM-1992 Program in PD | Parkinson's Disease Clinical Trials | |||
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lat | ALS News & Research | |||
Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development | ALS News & Research |